Connecting global healthcare decision-makers
with APAC's most transaction-ready healthcare innovations
Register Now
Register before August 31, 2026 to Save $850
What to Expect
Initiated by the GHIS International Healthcare Innovation Alliance, GHIS bridges East and West, connecting international pharmaceutical, medtech, and healthcare companies through curated partnering, transaction roadshows, and strategic networking.
Unrivaled Networking
Connect with 500+ attendees from across the biopharma, medtech, life sciences and investment sectors through 1000+ 1-on-1 meetings.
Cutting-Edge Content
Gain insights from top industry experts on biopharma & medtech trends, investment landscape, market expansion, and cross-border dealmaking.
Investment & Deal-Making Opportunities
Explore funding strategies, IPO potential, and M&A trends shaping APAC’s biopharma & medtech landscape, with 300+ unique companies in attendance and 100+ licensing opportunities.
Global Market Access
Learn how to navigate regulatory pathways and successfully expand into international markets, with participants from all over the world.
Four Tracks. One Ecosystem.
Biopharma | Medical Devices | Digital Health & AI | Life Sciences
0
Global Participating Companies
0
GHIS Transaction Roadshows
0
Industry Leaders & Speakers
0
Investment Institutions & Strategic Investors
0
Technology Forums & Panel Discussions
0
1-on-1 Partnering Meetings
Trusted By The Companies Pioneering What's Next
2026 Invited Speakers & Attendees
Industry-leading executives from MNCs, emerging companies, capital firms, and more.
Karsten D. Meier Vice President, Business Development & Strategy, Danaher Life Sciences – Omics Solutions Group Danaher
Daniel Nothelfer Vice President Business Development & Strategy, Life Sciences Innovations Group Danaher
Jason Peng Vice President and China Group Executive Danaher
Alex Gu Senior Vice President and President of Greater China Medtronic
June Chang President of Greater China Boston Scientific
Vincent Guercio Head of Strategy, Cytiva Genomic Medicine Danaher
Xiaoping Ye Chairman and Co-founder Tigermed
Xingpeng Wang Chairman Academy for Clinical Innova-tion & Translation of Shanghai
Ling Liu Chief Region Leader Philips Greater China
Qiang Lyu General Manager Hong Kong and Macau AstraZeneca
Zhenfu Li Founding Partner & CEO GL Capital
Michael Yi Founder & Chairman, Co-Chief Investment Officer Hillhouse Investment
Joel Yao Partner Sofinnova Partners - Biovelocita Strategy
Yuesheng Xin Senior Managing Director CITIC Capital
John Xu Founder and President Biorich International
Jay Wang CEO EverBridge Group
Wenjie Sheng Investment Director Sinopharm
Sandy Mou Board Executive Director and CEO Corxel
Chenxi Ouyang Deputy Secretary-General Chinese Society of Biomedical Engineering
Da Liu Managing Director CRCP Life Science Fund
Peiqiong Huo Chief Representative for the Greater Bay Area and International Business China Resources Pharmaceutical Commercial Group
Yaming Wang Founder and CEO Alphabet Health Group
Cheng Xing Managing Partner Sherpa Healthcare Partners
Fei Qi Executive Director Legend Capital
Jiangfeng Li Partner and Head of Healthcare Fortune Capital
Bo Ban Partner YuanBio Venture Capital
Kun Yang Partner Gaorong Capital
Xiangdong Xu Deputy General Manager Shenzhen Angel Fund of Funds
Zheng Zang Executive Director, Investment Banking Morgan Stanley
Lin Yi Partner GL Capital
Anita Wei Vice President of External Affairs of Danaher Group China Danaher
Vivek Y. Reddy Director of Cardiac Arrhythmia The Mount Sinai Hospital
Joy Song CFO, VP Finance & Business Development Ventures, Greater China Medtronic
Xiaonan Zheng Executive Vice Chairman & Secretary-General CBIITA
Jian'an Wang President, Director of the Heart Center Second Affiliated Hospital of Zhejiang University School of Medicine
Gaojun Teng Academician of Chinese Acad- emy of Sciences MD, FSIR, FCIRSE Zhongda Hospital, Southeast University
Jizong Zhao Academician of Chinese Academy of Sciences Director National Clinical Research Center for Neurological Dis-eases
Guangzhong Yang Fellow of the Royal Academyof Engineering (UK) Founding DirectorInstitute of Medical Robotics,Shanghai Jiao Tong University
Jeffrey Golden Executive Vice Dean of Re-search and Education Cedars-Sinai Medical Center,U.S.
Reinoud E. Knops Cardiologist/Electrophysiolo- gist trophysiology Department of Clinical Elec- Amsterdam University Medi- cal Center
Wojciech Chrzanowski Head of Pharmaceutical Sci-ences, Sydney Pharmacy School Leader Nano Medical Innovations Group, The University of Sydney
2026 Presenting Companies
Present to a full house of investors and strategics alongside the
CEOs and Founders building technology that is shaping the
future of healthcare.
Plan Your Stay in
Hong Kong
GHIS 2026 HK will be held at Grand Hyatt Hong Kong. In addition to the venue hotel, GHIS will provide registered attendees with access to selected nearby hotels at preferred rates, covering a range of accommodation options to suit different budgets, schedules, and travel preferences.
Learn More
Connecting Global Healthcare
Innovation Beyond the Annual Summit
GHIS is committed to building a connected international platform where innovators, industry leaders,
investors and healthcare organizations can engage throughout the year-not only during the annual
summit, but also at key moments across the global healthcare calendar.
2027
January
J.P.Morgan Healthcare Week
GHIS Satellite Program
June
American Society of Clinical Oncology(ASCO)
GHIS Satellite Program
 
The American Diabetes Association's (ADA's) Scientific Sessions
GHIS Satellite Program
October
Global Healthcare Innovation Summit(GHIS)
Annual Flagship Summit
 
Transcatheter Cardiovascular Therapeutics® Conference (TCT)
GHIS Satellite Program
More to Come
Additional Global Healthcare Conferences
Future GHIS Programs
GHIS 2025 Photo Highlights
GHIS provides a valuable window into emerging healthcare innovation and a highly efficient way to meet companies that are ready for global partnerships.
Head of Search & Evaluation, Global Pharma
GHIS stands out for its ability to connect scientific innovation with industry and capital. It is a valuable platform for companies looking to expand internationally.
Founder, Life Science Company
One of the few events where meaningful partnership discussions can happen in a highly efficient setting.
VP Business Development, Global MedTech